Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Capital Ltd
OTC:CAPFF
|
UK |
|
Basf Se
XETRA:BAS
|
DE |
|
Preferred Bank
NASDAQ:PFBC
|
US |
|
M
|
Medtronic PLC
DUS:2M6
|
IE |
|
Lument Finance Trust Inc
F:70X
|
US |
|
Italian Wine Brands S.P.A.
MIL:IWB
|
IT |
|
Banco de Sabadell SA
F:BDS
|
ES |
|
P
|
Pierre et Vacances SA
F:PV6
|
FR |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
S
|
Site Centers Corp
F:DDR2
|
US |
|
Tenaris SA
MIL:TEN
|
LU |
|
S
|
Sempra Energy
LSE:0L5A
|
US |
|
C
|
Cameco Corp
F:CJ6
|
CA |
|
NEC Corp
TSE:6701
|
JP |
|
T
|
Transocean Ltd
F:TOJ
|
CH |
|
Daiwa House Industry Co Ltd
F:DWH
|
JP |
|
I
|
ITV PLC
SWB:IJ7
|
UK |
|
T
|
Targa Resources Corp
F:TAR
|
US |
|
AST SpaceMobile Inc
NASDAQ:ASTS
|
US |
|
S
|
SunCoke Energy Inc
SWB:S01
|
US |
|
J
|
Japan Real Estate Investment Corp
F:JUA
|
JP |
|
Mon Courtier Energie SAS
F:O4Z
|
FR |
|
M
|
Markel Corp
LSE:0JYM
|
US |
Bankruptcy Probability
Capricor Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Capricor Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
1.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Capricor Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Capricor Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
